Biotech GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight July 5, 2025
Biotech Pond Technologies Holdings Inc. Announces Filing of 2025 First Quarter Unaudited Condensed Interim Financial Statements and MD&A July 2, 2025
Biotech Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London July 1, 2025
Biotech ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment June 30, 2025